---
category: news
title: "Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I.\") and machine learning (\"M.L.\") platform to transform the cost,"
publishedDateTime: 2022-11-07T21:18:00Z
originalUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
webUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "3jo1AMzEKQTTBTXWiCmaFYd3meGibSetIqLCmFVpu8R2VRrIe6w9C2niO4TJ/VDUr/j69IJtX2ChT8TJjVo30nJTWxFLrJnEX0Y5NuS26yc0/uMyXXyVIyXBUCOkARWdS1iYj3YEO341YWq12w/x7m5qKF2UQ7AOqViXeyUKmHaX/WPvcoU3HMXJItThqc2iCbvGFJIwdMAmASQRbrT/t3NCaw9/9cO4rkbvakEkRLfn35+mesVONdeG5kXY2zQxHw0Yg8mQFGMEvTVNNL+nzWkcOejNRhs1A2avKPnONyigJI/PHJFfZXKY1Wpi2qYurCjGsXclLGBIC84AVi8ZP+a2X1bgVWpNqmUxVv59ZYs=;0kT4Zos7CljbZQcogEWwWw=="
---

